SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
America's Car-Mart reported a fiscal year loss of $16.79 per share due to lower revenues and increased charge-offs. The company amended its credit agreement to address covenant com…
Central Plains Bancshares entered a Change in Control Agreement with Executive Bradley M. Kool effective July 8, 2026. The document defines severance benefits and employment terms …
Institutional holdings report (13F-HR) filed by CWA Asset Management Group, LLC.
Ligand Pharmaceuticals completed the acquisition of XOMA Royalty for $39.00 per share following the deal's closing. The transaction includes a contingent value right for pending li…
SUI Group announced the resignation of CIO Stephen Mackintosh effective July 8. The board will manage the transition while evaluating a new management structure for future growth.
Institutional holdings report (13F-HR) filed by Cox Capital Mgt LLC.
The company settled approximately $3.3 million in legacy liabilities and approved a 1-for-4 reverse stock split. This move is intended to bolster balance sheet strength and ensure …
FlyExclusive Inc. filed Amendment No. 5 to its merger agreement with Jet.AI Inc. The update modifies calculations regarding net liquidation proceeds to refine the determination of …
Institutional holdings report (13F-HR) filed by 13F-HR/A - Trust Asset Management LLC (0001608376) (Filer).
Institutional holdings report (13F-HR) filed by Sompo Asset Management Co., Ltd..
First Bancorp /NC/ has entered into an agreement to merge with First Carolina Bancshares. This reorganization consolidates the two financial institutions into a single entity.
Institutional holdings report (13F-HR) filed by Brewster Financial Planning LLC.
Holley Performance Brands repaid $15 million in debt from free cash flow, bringing cumulative repayments to $115 million since 2023. This deleveraging strategy supports the company…
SS Innovations International entered into an employment agreement with Sarah M. Romano to serve as Chief Financial Officer starting August 3, 2026. This long-term appointment reinf…
Syndax Pharmaceuticals unveiled two new pipeline assets, a mutant-selective EGFR inhibitor and a next-generation menin inhibitor, and confirmed the Phase 2 trial of axatilimab is o…
Runway Growth’s management and adviser announced a plan to repurchase up to 10% of outstanding shares over the next two years. This move supports the stock as it trades at a signif…
Diodes Incorporated and GN Merger Sub Inc. executed an Agreement and Plan of Merger to acquire Elevate Semiconductor Inc. This strategic acquisition aims to leverage Elevate's tech…
VYNE Therapeutics filed Exhibit 99.1 detailing a proposed reverse merger with Yarrow Bioscience and concurrent financing. This corporate restructuring could provide VYNE's preclini…
Inhibikase sold 25 million shares to RA Capital Management for $50 million gross proceeds. The funds are intended to support the IMPROVE-PAH Phase 3 study through topline data.
Institutional holdings report (13F-HR) filed by Brown Shipley& Co Ltd.